Clinical Trials for CBD Type 1 Diabetes are coming!

By: dryoiledible
Updated on: October 15, 2020 at 12:16 pm

There are few medical conditions less dangerous than diabetes. More than 40 million people under the age of 19 worldwide are diagnosed with Type 1 Diabetes. These numbers have been on a steady rise and will likely continue, unless there are significant medical breakthroughs that can successfully curve them downward.

A downward trend may be possible.

Type 1 Diabetes is found mostly in children and young adults and occurs when the body does not produce enough of the hormone insulin that allows the body to absorb and use sugar. It is an autoimmune disorder where a person’s immune system attacks and destroys healthy tissue in the pancreas, preventing it from naturally producing insulin.

Once diagnosed with the condition it becomes a lifelong battle with the need to manually replace the required insulin on a daily basis (often, several times per day).

Type 1 Diabetes may affect different people in different ways, but overall the physical effects are:

  • Frequent urination
  • Problems with eyesight
  • Increased thirst
  • Increased hunger
  • Fatigue and constantly feeling tired
  • Weight loss

Currently, the treatment for people with Type 1 Diabetes include taking several insulin shots a day, using an insulin pump or inhaling insulin. Without treatment, a person can develop more serious and chronic conditions relating to other parts of the body including the kidney and heart.


Type 1 Diabetes is being studied by brilliant researchers and scientists around the world. Recently Imperial College London did a study that found that the number of children diagnosed with type 1 diabetes almost doubled during the peak of the Covid-19 pandemic in the UK.

The findings suggested a co-relation between the two conditions and further investigations are now ongoing to determine if there is a direct link.

Of interest, the researchers suggested that one reason for the increased number of cases for Type 1 Diabetes may be due to the spike in protein, “the sole viral membrane protein responsible for cell entry, caused by coronavirus potentially attacking insulin-producing cells in the pancreas”.

This was the first study globally, that established an association between the Covid-19 virus and the onset of Type 1 Diabetes in young people.

There are hundreds of other studies being conducted around the world, all seeking solutions and treatments for Type 1 Diabetes.

However, there are no studies or clinical trials focused on the use of CBD as a solution.


A few months ago, renowned research scientist and the world’s most foremost thinker of all things CBD, Dr. Raphael Mechoulam, completed a study in mice that was successful in the treatment of Type 1 Diabetes by cannabidiol.

His team has detailed sources and methods and compiled a report of the findings.

In a collaborative effort, (we) are now engaged in taking their findings of studies in mice and setting up the necessary framework to carry out studies of the use of CBD as a treatment for people with Type 1 Diabetes, with clinical trials.

This will be the first time ever, that human trials have been conducted with the use of CBD anywhere in the world.

This story will run continuously and be frequently updated from set-up to conclusion. An announcement of the start of the trials will be made. This is an ongoing story.

0 0 vote
Article Rating
Notify of
Inline Feedbacks
View all comments